Dr. Apte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Forest Park Ave
Fl 6
Saint Louis, MO 63108Phone+1 314-362-3937Fax+1 314-362-3725
Summary
- Dr. Rajendra Apte is an ophthalmologist in Saint Louis, MO. He is the Paul A. Cibis Distinguished Professor and Vice Chair of Innovation and Translation at Washington University in St. Louis School of Medicine and Barnes Hospital. He received his medical degree from University of Bombay. He did his graduate thesis and residency at Parkland Hospital/UT Southwestern and his vitreoretinal fellowship at Johns Hopkins Wilmer Eye Institute and has been in practice 20 years. He specializes in retinal disease and is experienced in diabetic retinopathy, macular degeneration, retina surgery, vitreoretinal disease, and electrophysiology of vision. He has more than 150 publications and over 5000 citations. He is world renowned as a surgeon, innovator, entrepreneur and scientist.
Education & Training
- LTMMCClass of 1992
Certifications & Licensure
- IL State Medical License 2000 - 2026
- MO State Medical License 2003 - 2026
- MD State Medical License 2001 - 2004
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.Wilson X Wang, Dan Spiegelman, P Kumar Rao, Rennie L Rhee, Andria L Ford
The Journal of Clinical Investigation. 2024-12-16 - Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, Katrin Beckmann, Rajendra S Apte
JAMA Ophthalmology. 2024-10-01 - 2 citationsCholesterol Accumulation Promotes Photoreceptor Senescence and Retinal Degeneration.Ryo Terao, Brian S Sohn, Taku Yamamoto, Tae Jun Lee, Jason Colasanti
Investigative Ophthalmology & Visual Science. 2024-08-01
Press Mentions
- Repurposed Drug May Help Stabilize Vision in Rare DiseaseJune 17th, 2024
- No Visual Acuity Benefit with Early Anti-VEGF for Diabetic RetinopathyFebruary 7th, 2023
- Stem Cell Advances Might Help Dry Eye Disease, Researchers SayJanuary 4th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: